Large-scale data STATinMED offers real-time, multi-source health data covering 300 million deidentified patients with payer and provider transaction-level insights, enabling health economics and outcomes research teams to underpin market access, pricing, and value proposition strategies for life science clients.

RWD registry Recent launch of RWD Custom Registry creates a pull-through opportunity to upsell customized data collection and registry design services for sponsors seeking real-world evidence and post-market surveillance across diverse therapeutic areas.

Rapid onboarding Fast project kick-off within one week and uninterrupted data access can be highlighted to prospects as a competitive advantage for accelerating HEOR studies, payer analyses, and market access timelines for new products.

Therapeutic breadth With coverage across hundreds of therapeutic areas and 97% of healthcare professional specialties, STATinMED can tailor insights to a wide range of drug, device, and diagnostics programs, expanding potential client fit beyond niche indications.

Strategic partnerships Historically involved in acquisitions and executive leadership appointments, STATinMED has demonstrated capital and leadership stability, suggesting opportunities to position as a strategic data partner for larger CROs, payers, and biopharma alliances seeking HEOR and outcomes capabilities.